Abstract
A cancer biomarker is a substance that indicates the presence of cancer. It could be secreted by a tumor or result from a specific response to the cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. This chapter outlines the sources of the most up-to-date information on the regulatory bodies, journals on biomarkers, journals on cancer, professional bodies, books, emerging techniques and platforms, and websites that are relevant to an evidence-based use of biomarkers in health and disease.
Similar content being viewed by others
References
Atkinson AJ, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF, Oates JA, Peck CC, Schooley RT, Spilker BA, Woodcock J, Zeger SL. NCI-FDA Biomarkers Definitions Working Group; Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89–95.
Acknowledgement
We would like to thank the following authors for contributing to the development of this resource (Carnero A, Clarke S, De Rossi A, Diakos C, Noh D-Y, Schraml PH, Takenaka S, Wonshik H, Yi L).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Rajendram, R., Rajendram, R., Patel, V.B., Preedy, V.R. (2014). Biomarkers in Health and Disease: Cancer What More Is There to Know?. In: Preedy, V., Patel, V. (eds) Biomarkers in Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7744-6_47-1
Download citation
DOI: https://doi.org/10.1007/978-94-007-7744-6_47-1
Received:
Accepted:
Published:
Publisher Name: Springer, Dordrecht
Online ISBN: 978-94-007-7744-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences